Hu, J., Zhang, B., Yao, F., Fu, Y., Chen, D., Li, D., . . . Li, X. (2020). Acquired multiple mutations ALK I1171N, L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: A case report. Ther Adv Respir Dis.
Citación estilo ChicagoHu, Jia, et al. "Acquired Multiple Mutations ALK I1171N, L1196M and G1202R Mediate Lorlatinib Resistance in EML4-ALK-rearranged Malignant Pleural Mesothelioma: A Case Report." Ther Adv Respir Dis 2020.
Cita MLAHu, Jia, et al. "Acquired Multiple Mutations ALK I1171N, L1196M and G1202R Mediate Lorlatinib Resistance in EML4-ALK-rearranged Malignant Pleural Mesothelioma: A Case Report." Ther Adv Respir Dis 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.